AlphaHelix Molecular Diagnostics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Mikael Havsjo
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.2yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Do AlphaHelix Molecular Diagnostics's (NGM:ALPH) Earnings Warrant Your Attention?
Jun 02
Should You Be Adding AlphaHelix Molecular Diagnostics (NGM:ALPH) To Your Watchlist Today?
Feb 10I Ran A Stock Scan For Earnings Growth And AlphaHelix Molecular Diagnostics (NGM:ALPH) Passed With Ease
Nov 03AlphaHelix Molecular Diagnostics AB (publ) (NGM:ALPH) Stock Rockets 35% As Investors Are Less Pessimistic Than Expected
Aug 18Do Its Financials Have Any Role To Play In Driving AlphaHelix Molecular Diagnostics AB (publ)'s (NGM:ALPH) Stock Up Recently?
Mar 07Declining Stock and Decent Financials: Is The Market Wrong About AlphaHelix Molecular Diagnostics AB (publ) (NGM:ALPH)?
Nov 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -kr11m |
| Dec 31 2023 | n/a | n/a | -kr9m |
| Sep 30 2023 | n/a | n/a | -kr5m |
| Jun 30 2023 | n/a | n/a | -kr4m |
| Mar 31 2023 | n/a | n/a | -kr4m |
| Dec 31 2022 | n/a | n/a | -kr2m |
| Sep 30 2022 | n/a | n/a | -kr2m |
| Jun 30 2022 | n/a | n/a | -kr990k |
| Mar 31 2022 | n/a | n/a | kr5m |
| Dec 31 2021 | kr95k | kr95k | kr5m |
| Sep 30 2021 | n/a | n/a | kr5m |
| Jun 30 2021 | n/a | n/a | kr5m |
| Mar 31 2021 | n/a | n/a | kr2m |
| Dec 31 2020 | kr114k | kr107k | kr2m |
| Sep 30 2020 | n/a | n/a | kr1m |
| Jun 30 2020 | n/a | n/a | kr916k |
| Mar 31 2020 | n/a | n/a | kr205k |
| Dec 31 2019 | kr271k | kr189k | -kr983k |
| Sep 30 2019 | n/a | n/a | -kr1m |
| Jun 30 2019 | n/a | n/a | -kr1m |
| Mar 31 2019 | n/a | n/a | -kr801k |
| Dec 31 2018 | kr82k | n/a | -kr1m |
| Sep 30 2018 | n/a | n/a | -kr1m |
| Jun 30 2018 | n/a | n/a | -kr2m |
| Mar 31 2018 | n/a | n/a | -kr3m |
| Dec 31 2017 | kr82k | n/a | -kr766k |
Compensation vs Market: Insufficient data to establish whether Mikael's total compensation is reasonable compared to companies of similar size in the Swedish market.
Compensation vs Earnings: Mikael's compensation has been consistent with company performance over the past year.
CEO
Mikael Havsjo (67 yo)
13.2yrs
Tenure
kr95,000
Compensation
Mr. Mikael Havsjö serves as the Chief Executive Officer at AlphaHelix Molecular Diagnostics AB (publ) and Techtum Lab AB. He was the Chairman of AlphaHelix Molecular Diagnostics AB (publ) and has been its...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | no data | kr733.00k | no data | |
| CEO & Director | 13.2yrs | kr95.00k | no data | |
| Director of Cybergene AB | no data | kr605.00k | no data | |
| Director | 6.3yrs | kr50.00k | no data | |
| Director | 4.3yrs | kr50.00k | no data | |
| Director of Techtum Lab AB | no data | kr872.00k | no data | |
| Director | 1.6yrs | no data | no data |
5.3yrs
Average Tenure
54yo
Average Age
Experienced Board: ALPH's board of directors are considered experienced (5.3 years average tenure).